Milategrast
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01221818)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e6007
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03444818 | Phase 1 | Apr 17, 2018 | EA Pharma Co., Ltd. |
| NCT03018054 | Phase 2 | Nov 28, 2016 | EA Pharma Co., Ltd. |
| NCT02268838 | Phase 1 | Oct 1, 2014 | Eisai |
| NCT01221818 | Phase 1 | Sep 1, 2010 | Eisai |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EA Pharma Co., Ltd. | For profit | 2 | 2 | 2 | 2016 |
| Eisai | For profit | 2 | 2 | 1 | 2010 |
2 organizations
Page 1 / 1